نتایج جستجو برای: chemoresistance chemotherapy

تعداد نتایج: 117854  

Journal: :Archives of Medical Science 2021

Introduction Ovarian cancer (OC) frequently occurs in postmenopausal women and it has higher mortality rate. Accumulating researches proved that long non-coding RNA nuclear paraspeckle assembly transcript 1 (NEAT1) involved the progression of chemoresistance human OC. Here, study aimed to investigate partial molecular mechanism OC chemoresistance. Material methods The levels NEAT1 microRNA-320b...

2014
Jun Lin Qiang Zhang Yi Lu Wenrui Xue Yue Xu Yichen Zhu Xiaopeng Hu

UNLABELLED Cisplatin-based combination chemotherapy regimen is a reasonable alternative to cystectomy in advanced/metastatic bladder cancer, but acquisition of cisplatin resistance is common in patients with bladder cancer. Previous studies showed that loss of homeodomain-interacting protein kinase-2 (HIPK2) contributes to cell proliferation and tumorigenesis. However, the role of HIPK2 in regu...

Journal: : 2022

Backgraound . High-grade serous ovarian carcinoma (HGSOC) is the most common type of cancer. The prevalence BRCA1/2 germline mutations highest in HGSOC. patients with BRCA gene are more likely to respond platinum-based chemotherapy. Clinical trials demonstrate effectiveness PARP inhibitors treatment -associated Re-administration after response chemotherapy demonstrates an increase progression-f...

Journal: :Head & neck 2013
Miguel Caballero Aaron E Sosa Andrea Tagliapietra Juan J Grau

BACKGROUND Adenoid cystic carcinoma (ACC) of the salivary gland frequently develops lung metastases. In cases in which chemotherapy is indicated, resistance is a common phenomenon. New drugs, such as cetuximab, have been chosen to avoid this chemoresistance. METHODS AND RESULTS A 54-year-old man was diagnosed with ACC of the right submandibular gland. He underwent a submandibular gland resect...

Journal: :Mathematical biosciences and engineering : MBE 2016
Ami B Shah Katarzyna A Rejniak Jana L Gevertz

While chemoresistance in primary tumors is well-studied, much less is known about the influence of systemic chemotherapy on the development of drug resistance at metastatic sites. In this work, we use a hybrid spatial model of tumor response to a DNA damaging drug to study how the development of chemoresistance in micrometastases depends on the drug dosing schedule. We separately consider cell ...

2016
Chris Planque Fatemeh Rajabi Fanny Grillet Pascal Finetti François Bertucci Meritxell Gironella Juan José Lozano Bertrand Beucher Julie Giraud Véronique Garambois Charles Vincent Daniel Brown Ludovic Caillo Jovana Kantar André Pelegrin Michel Prudhomme Jérémie Ripoche Jean François Bourgaux Christophe Ginestier Antoni Castells Frédéric Hollande Julie Pannequin Jean Marc Pascussi

Colorectal cancer lethality usually results from post-treatment relapse in the majority of stage II-IV patients, due to the enhanced resistance of Cancer Stem Cells (CSCs). Here, we show that the nuclear receptor Pregnane X Receptor (PXR, NR1I2), behaves as a key driver of CSC-mediated tumor recurrence. First, PXR is specifically expressed in CSCs, where it drives the expression of genes involv...

Journal: :Molecular medicine reports 2015
Shanshan Shi Chenxing Yuan Kaizan Zhuang Guikai Liang Zhangting Yao Duoduo Wang Qinjie Weng Ji Cao Peihua Luo Hong Zhu Ling Ding Shenglin Ma

Hypoxia is associated with resistance to chemotherapy in a number of human cancer types; particularly in hepatocellular carcinoma (HCC), which is a highly vascularized tumor. To develop a potential combination therapy strategy that is capable of overcoming the hypoxia‑induced insensitivity to chemotherapy, the HCC cell SMMC‑7721 was employed to investigate the hypoxia‑induced chemoresistance to...

Journal: :Current medicinal chemistry. Anti-cancer agents 2005
Pascal Sève Charles Dumontet

The treatment of advanced non-small-cell lung cancer (NSCLC is based on the combination of platin and one of the following agents: taxanes, gemcitabine, vinorelbine or irinotecan. There are no significant differences in efficacy among these combinations suggesting that the maximum efficacy has been reached. In this review, we will consider the mechanisms of chemoresistance of the five groups of...

2013
Hifzur Rahman Siddique Aijaz Parray Rohinton S. Tarapore Lei Wang Hasan Mukhtar R. Jeffery Karnes Yibin Deng Badrinath R. Konety Mohammad Saleem

For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and paucity of knowledge about the mechanism of chemoresistance are major stumbling blocks in the management of this disease. Here, we provide compelling evidence that BMI1 polycomb group protein and a stem cell factor plays a crucial role in determining the fate of tumors vis-à-vis chemotherapy. We sh...

2017
Serena Mazzucchelli Michela Bellini Luisa Fiandra Marta Truffi Maria A. Rizzuto Luca Sorrentino Erika Longhi Manuela Nebuloni Davide Prosperi Fabio Corsi

Chemotherapeutic treatment of breast cancer is based on maximum tolerated dose (MTD) approach. However, advanced stage tumors are not effectively eradicated by MTD owing to suboptimal drug targeting, onset of therapeutic resistance and neoangiogenesis. In contrast, "metronomic" chemotherapy is based on frequent drug administrations at lower doses, resulting in neovascularization inhibition and ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید